Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
931,134
-
Share change
-
+134,533
-
Total reported value
-
$18,285,000
-
Price per share
-
$19.61
-
Number of holders
-
33
-
Value change
-
+$2,168,100
-
Number of buys
-
12
-
Number of sells
-
18
Institutional Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q1 2022
As of 31 Mar 2022,
Greenwich LifeSciences, Inc. - COM (GLSI) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
931,134 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, STATE STREET CORP, AMERIPRISE FINANCIAL INC, NORTHERN TRUST CORP, MORGAN STANLEY, MARSHALL WACE, LLP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, and Bank of New York Mellon Corp.
This page lists
33
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.